SVACF / SciVac Therapeutics Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

SciVac Therapeutics Inc.
US ˙ OTC
SIMBOL INI SUDAH TIDAK AKTIF LAGI

Saham milik Insider3.290.496 shares
Skor Sentimen Insider

Skor Sentimen Insider menemukan bahwa perusahaan-perusahaan tersebut dibeli oleh insider perusahaan.

Hal ini merupakan hasil dari model kuantitatif multifaktor yang canggih yang mengidentifikasi perusahaan-perusahaan dengan tingkat akumulasi insider tertinggi. Model penilaian menggunakan kombinasi jumlah bersih pembelian insider dalam 90 hari sebelumnya, total saham yang dibeli sebagai persentase float, dan total saham yang dimiliki oleh insider. Angka tersebut berkisar dari 0 hingga 100, dengan angka yang lebih tinggi menunjukkan tingkat akumulasi yang lebih tinggi terhadap rekan-rekannya, dan 50 adalah rata-ratanya.

Frekuensi Pembaruan: Harian

Lihat Pilihan Insider Teratas yang menyediakan daftar perusahaan dengan akumulasi insider tertinggi.

Skor Sentimen Pejabat

Skor Sentimen Pejabat menemukan perusahaan yang dibeli oleh Pejabat Perusahaan.

Menurut definisi, Pejabat Korporat adalah Insider Korporat, tetapi tidak seperti beberapa Insider lainnya (10% Pemegang Saham dan Anggota Dewan), Pejabat bekerja untuk perusahaan setiap hari, dan mereka menggunakan uang mereka sendiri saat berdagang . (10% Pemegang Saham dan Anggota Dewan sering kali merupakan pengelola dana yang mengelola uang orang lain.) Oleh karena itu, insider trading yang dilakukan oleh Pejabat jauh lebih signifikan dan harus diperlakukan dengan tepat.

Seperti Skor Sentimen Insider, Skor Sentimen Pejabat adalah hasil model kuantitatif multifaktor yang canggih yang mengidentifikasi perusahaan dengan tingkat akumulasi pejabat tertinggi.

Frekuensi Pembaruan: Harian

Lihat Pilihan Insider Teratas yang menyediakan daftar perusahaan dengan sentimen insider tertinggi.

Metrik Utama Insider

Kartu ini menunjukkan peringkat perusahaan berdasarkan berbagai metrik insider. Peringkat persentil menunjukkan perbandingan perusahaan ini dengan perusahaan lain di pasar AS. Peringkat yang lebih tinggi menunjukkan situasi yang lebih baik.

Misalnya, secara umum diterima bahwa pembelian insider adalah indikator positif, sehingga perusahaan dengan lebih banyak pembelian insider akan memiliki peringkat lebih tinggi dibandingkan perusahaan dengan lebih sedikit pembelian insider (atau bahkan penjualan insider).

Jumlah Bersih Pembelian Insider (Peringkat)

N/A

Jumlah Bersih Pembelian Insider adalah jumlah total pembelian insider dikurangi jumlah total pembelian insider dalam 90 hari terakhir. Peringkat persentil ditampilkan di sini (berkisar dari 0 hingga 100%).

Persentase Float yang Dibeli oleh Insider (Peringkat)

N/A

Persen Float yang Dibeli oleh Insider adalah jumlah total saham yang dibeli oleh insider dikurangi jumlah total saham yang dijual oleh insider dalam 90 hari terakhir, dibagi dengan total float dan dikalikan 100.

Grafik Perdagangan Insider

SciVac Therapeutics Inc. perdagangan insider ditunjukkan pada diagram berikut. Insider adalah pejabat, direktur, atau investor penting dalam suatu perusahaan. Secara umum, merupakan tindakan ilegal bagi insider untuk melakukan perdagangan di perusahaannya berdasarkan informasi penting yang bersifat non-publik. Hal ini tidak berarti bahwa mereka dilarang melakukan perdagangan apa pun di perusahaan mereka sendiri. Namun, mereka harus melaporkan semua perdagangan ke SEC melalui Formulir 4.

Daftar Insider dan Metrik Profitabilitas

Tabel ini menunjukkan daftar insider yang dikenal, dan dihasilkan secara otomatis dari pengajuan yang diungkapkan kepada SEC. Selain nama, jabatan terbaru, dan direktur, pejabat, atau 10% pemilik, kami juga menyediakan pengungkapan kepemilikan terkini. Selain itu, jika memungkinkan, kami memberikan riwayat kinerja perdagangan kepada insider. Kinerja perdagangan historis merupakan rata-rata tertimbang dari kinerja transaksi pembelian aktual di pasar terbuka yang dilakukan oleh insider. Untuk informasi selengkapnya tentang cara menghitungnya, tonton webinar YouTube ini.

See our leaderboard of most profitable insider traders.

Insider Laba Rata-Rata (%) Saham
Dimiliki
Membelah
Disesuaikan

Report errors via our new Insider Auditing Tool

Rekam Jejak Pembelian Insider - Analisis Keuntungan Jangka Pendek

Di bagian ini, kami menganalisis profitabilitas setiap pembelian insider di pasar terbuka yang tidak direncanakan dan dilakukan pada SVACF / SciVac Therapeutics Inc.. Analisis ini membantu untuk memahami apakah insider secara konsisten menghasilkan keuntungan yang tidak normal, dan layak untuk diikuti. Analisis ini untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut ini menunjukkan pembelian pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Insider Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari ke
Maksimal
Harga di
Maksimal
Maksimal
Keuntungan ($)
Pengembalian Maksimal (%)
2023-07-10 GILLIS STEVEN 609.090 1,6500 609.090 1,6500 1.004.998 9 1.5000 -91.363 -9,09
2021-12-03 Beattie Nell 8.200 2,4492 273 73,4760 20.083
2020-04-24 PERCEPTIVE ADVISORS LLC 9.090.909 1,1000 303.030 33,0000 10.000.000
2019-10-04 Diaz-Mitoma Francisco 40.000 0,5000 1.333 15,0000 20.000
2019-10-01 McNulty Christopher 12.000 0,4730 400 14,1900 5.676
2019-10-01 Beattie Nell 10.000 0,4822 333 14,4660 4.822
2019-09-30 Baxter Jeff 150.000 0,5030 5.000 15,0900 75.450
2019-09-30 Diaz-Mitoma Francisco 14.500 0,5000 483 15,0000 7.250
2019-09-23 PERCEPTIVE ADVISORS LLC 20.000.000 0,5000 666.667 15,0000 10.000.000

Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.

SVACF / SciVac Therapeutics Inc. Insider Trades
Rekam Jejak Penjualan Insider - Analisis Kerugian Jangka Pendek

Di bagian ini, kami menganalisis penghindaran kerugian jangka pendek dari setiap penjualan insider di pasar terbuka yang tidak direncanakan dan dilakukan di SVACF / SciVac Therapeutics Inc.. Pola penghindaran kerugian yang konsisten mungkin menunjukkan bahwa transaksi penjualan pada masa depan dapat memprediksi penurunan harga. Analisis ini untuk satu tahun setelah setiap perdagangan, dan hasilnya bersifat teoritis .

Tabel berikut menunjukkan penjualan pasar terbuka terkini yang bukan merupakan bagian dari rencana perdagangan otomatis.

Tanggal Perdagangan Insider Dilaporkan
Saham
Dilaporkan
Harga
Disesuaikan
Saham
Disesuaikan
Harga
Dasar Biaya Hari ke
Minimal
Harga di
Minimal
Kerugian Maksimal
Dihindari ($)
Kerugian Maksimal
Dihindari (%)
2023-04-06 PERCEPTIVE ADVISORS LLC 4.251.563 0,1100 141.719 3,3000 467.672 202 0.4960 -397.379 -84,97
2023-04-05 PERCEPTIVE ADVISORS LLC 1.832.563 0,1300 61.085 3,9000 238.233
2023-04-04 PERCEPTIVE ADVISORS LLC 4.810.623 0,1600 160.354 4,8000 769.700
2021-12-01 PERCEPTIVE ADVISORS LLC 2.707.463 3,3100 90.249 99,3000 8.961.703
2021-06-29 PERCEPTIVE ADVISORS LLC 500.709 3,8000 16.690 114,0000 1.902.694
2021-06-29 PERCEPTIVE ADVISORS LLC 145.548 3,8000 4.852 114,0000 553.082
2021-06-09 PERCEPTIVE ADVISORS LLC 1.102.179 4,0000 36.739 120,0000 4.408.716
2021-06-09 PERCEPTIVE ADVISORS LLC 320.388 4,0000 10.680 120,0000 1.281.552

Harga yang Disesuaikan adalah harga yang disesuaikan secara terpisah. Saham yang Disesuaikan adalah saham yang disesuaikan dengan pembagiannya.

SVACF / SciVac Therapeutics Inc. Insider Trades
Riwayat Transaksi

Klik ikon tautan untuk melihat riwayat transaksi lengkap. Transaksi yang dilaporkan sebagai bagian dari rencana perdagangan otomatis 10b5-1 akan ditandai X di kolom bertanda 10b-5.

Mengajukan
Tanggal
Transaksi
Tanggal
Formulir Insider Kode Judul Keamanan Kode 10b5-1 Langsung Latihan
Harga
Satuan
Harga
Satuan
Berubah
Nilai
Berubah (1K)
Tersisa
Opsi
Tersisa
Saham
2023-07-18 2023-07-10 4 GILLIS STEVEN See Footnotes VBIV Common Shares, no par value per share P - Purchase I 1,6500 609.090 1.005 1.043.292
2023-04-06 2023-04-06 4 PERCEPTIVE ADVISORS LLC VBIV Common Stock S - Sale I 0,1100 -4.251.563 -468 41.440.729
2023-04-06 2023-04-05 4 PERCEPTIVE ADVISORS LLC VBIV Common Stock S - Sale I 0,1300 -1.832.563 -238 45.691.816
2023-04-06 2023-04-04 4 PERCEPTIVE ADVISORS LLC VBIV Common Stock S - Sale I 0,1600 -4.810.623 -770 47.524.379
2022-01-31 2022-01-27 4 DeWilde Michel VBIV Option (Right to Buy Common Shares) A - Award D 1,53 75.000 75.000
2022-01-31 2022-01-27 4 McNulty Christopher VBIV Option (Right to Buy Common Shares) A - Award D 1,53 400.000 400.000
2022-01-31 2022-01-27 4 McKee Blaine H. VBIV Option (Right to Buy Common Shares) A - Award D 1,53 75.000 75.000
2022-01-31 2022-01-27 4 Mazaltov Avi VBIV Option (Right to Buy Common Shares) A - Award D 1,53 400.000 400.000
2022-01-31 2022-01-27 4 GILLIS STEVEN VBIV Option (Right to Buy Common Shares) A - Award D 1,53 100.000 100.000
2022-01-31 2022-01-27 4 Diaz-Mitoma Francisco VBIV Option (Right to Buy Common Shares) A - Award D 1,53 400.000 400.000
2022-01-31 2022-01-27 4 Cordeiro Joanne VBIV Option (Right to Buy Common Shares) A - Award D 1,53 75.000 75.000
2022-01-31 2022-01-27 4 Braga Damian VBIV Option (Right to Buy Common Shares) A - Award D 1,53 75.000 75.000
2022-01-31 2022-01-27 4 Beattie Nell VBIV Option (Right to Buy Common Shares) A - Award D 1,53 400.000 400.000
2022-01-31 2022-01-27 4 Baxter Jeff VBIV Option (Right to Buy Common Shares) A - Award D 1,53 800.000 800.000
2022-01-31 2022-01-27 4 Bain Linda VBIV Option (Right to Buy Common Shares) A - Award D 1,53 75.000 75.000
2022-01-31 2022-01-27 4 Anderson David Evander VBIV Option (Right to Buy Common Shares) A - Award D 1,53 400.000 400.000
2021-12-06 2021-12-03 4 Beattie Nell VBIV Common Shares, no par value per share P - Purchase D 2,4492 8.200 20 68.200
2021-12-03 2021-12-01 4 PERCEPTIVE ADVISORS LLC VBIV Common Stock S - Sale I 3,3100 -2.707.463 -8.962 52.334.993
2021-07-07 2021-07-01 4 Bain Linda VBIV Option (Right to Buy Common Shares) A - Award D 3,43 250.000 250.000
2021-06-30 2021-06-29 4 PERCEPTIVE ADVISORS LLC VBIV Common Stock S - Sale I 3,8000 -145.548 -553 0
2021-06-30 2021-06-29 4 PERCEPTIVE ADVISORS LLC VBIV Common Stock S - Sale I 3,8000 -500.709 -1.903 0
2021-06-11 2021-06-09 4 PERCEPTIVE ADVISORS LLC VBIV Warrant (right to buy) X - Other I 2,75 -465.936 0
2021-06-11 2021-06-09 4 PERCEPTIVE ADVISORS LLC VBIV Warrant (right to buy) X - Other I 2,75 -1.602.888 0
2021-06-11 2021-06-09 4 PERCEPTIVE ADVISORS LLC VBIV Common Stock S - Sale I 4,0000 -320.388 -1.282 145.548
2021-06-11 2021-06-09 4 PERCEPTIVE ADVISORS LLC VBIV Common Stock S - Sale I 4,0000 -1.102.179 -4.409 500.709
2021-06-11 2021-06-09 4 PERCEPTIVE ADVISORS LLC VBIV Common Stock X - Other I 2,7500 465.936 1.281 465.936
2021-06-11 2021-06-09 4 PERCEPTIVE ADVISORS LLC VBIV Common Stock X - Other I 2,7500 1.602.888 4.408 1.602.888
2021-02-01 2021-01-27 4 DeWilde Michel VBIV Option (Right to Buy Common Shares) A - Award D 3,15 75.000 75.000
2021-02-01 2021-01-27 4 Mazaltov Avi VBIV Option (Right to Buy Common Shares) A - Award D 3,14 500.000 500.000
2021-01-29 2021-01-27 4 McKee Blaine H. VBIV Option (Right to Buy Common Shares) A - Award D 3,15 75.000 75.000
2021-01-29 2021-01-27 4 Diaz-Mitoma Francisco VBIV Option (Right to Buy Common Shares) A - Award D 3,14 500.000 500.000
2021-01-29 2021-01-27 4 Braga Damian VBIV Option (Right to Buy Common Shares) A - Award D 3,15 75.000 75.000
2021-01-29 2021-01-27 4 Beattie Nell VBIV Option (Right to Buy Common Shares) A - Award D 3,15 500.000 500.000
2021-01-29 2021-01-27 4 Cordeiro Joanne VBIV Option (Right to Buy Common Shares) A - Award D 3,15 75.000 75.000
2021-01-29 2021-01-27 4 McNulty Christopher VBIV Option (Right to Buy Common Shares) A - Award D 3,15 500.000 500.000
2021-01-29 2021-01-27 4 Anderson David Evander VBIV Option (Right to Buy Common Shares) A - Award D 3,15 500.000 500.000
2021-01-29 2021-01-27 4 GILLIS STEVEN VBIV Option (Right to Buy Common Shares) A - Award D 3,15 100.000 100.000
2021-01-29 2021-01-27 4 Baxter Jeff VBIV Option (Right to Buy Common Shares) A - Award D 3,15 1.000.000 1.000.000
2020-07-02 2020-07-01 4 Baxter Jeff VBIV Option (Right to Buy Common Shares) A - Award D 2,94 425.200 425.200
2020-07-02 2020-07-01 4 Diaz-Mitoma Francisco VBIV Option (Right to Buy Common Shares) A - Award D 2,99 167.150 167.150
2020-07-02 2020-07-01 4 Mazaltov Avi VBIV Option (Right to Buy Common Shares) A - Award D 2,99 167.150 167.150
2020-07-02 2020-07-01 4 McNulty Christopher VBIV Option (Right to Buy Common Shares) A - Award D 2,94 170.100 170.100
2020-07-02 2020-07-01 4 Beattie Nell VBIV Option (Right to Buy Common Shares) A - Award D 2,94 170.100 170.100
2020-07-02 2020-07-01 4 Anderson David Evander VBIV Option (Right to Buy Common Shares) A - Award D 2,94 170.100 170.100
2020-04-28 2020-04-24 4 PERCEPTIVE ADVISORS LLC VBIV Common Stock P - Purchase I 1,1000 9.090.909 10.000 55.042.456
2020-03-24 2020-03-24 4 Braga Damian VBIV Option (Right to Buy Common Shares) A - Award D 0,81 250.000 250.000
2020-01-24 2020-01-22 4 McKee Blaine H. VBIV Option (Right to Buy Common Shares) A - Award D 1,46 250.000 250.000
2020-01-24 2020-01-22 4 GILLIS STEVEN VBIV Option (Right to Buy Common Shares) A - Award D 1,46 350.000 350.000
2020-01-24 2020-01-22 4 McNulty Christopher VBIV Option (Right to Buy Common Shares) A - Award D 1,46 350.000 350.000
2020-01-24 2020-01-22 4 Beattie Nell VBIV Option (Right to Buy Common Shares) A - Award D 1,46 350.000 350.000
2020-01-24 2020-01-22 4 Cordeiro Joanne VBIV Option (Right to Buy Common Shares) A - Award D 1,46 250.000 250.000
2020-01-24 2020-01-22 4 Diaz-Mitoma Francisco VBIV Option (Right to Buy Common Shares) A - Award D 1,66 350.000 350.000
2020-01-24 2020-01-22 4 Anderson David Evander VBIV Option (Right to Buy Common Shares) A - Award D 1,46 350.000 350.000
2020-01-24 2020-01-22 4 Mazaltov Avi VBIV Restricted Stock Units A - Award D 50.000 50.000
2020-01-24 2020-01-22 4 DeWilde Michel VBIV Option (Right to Buy Common Shares) A - Award D 1,46 250.000 250.000
2020-01-24 2020-01-22 4 Baxter Jeff VBIV Option (Right to Buy Common Shares) A - Award D 1,46 500.000 500.000
2019-10-07 2019-10-04 4 Diaz-Mitoma Francisco VBIV Common Shares, no par value per share P - Purchase I 0,5000 40.000 20 117.500
2019-10-07 2019-09-30 4 Diaz-Mitoma Francisco By wife VBIV Common Shares, no par value per share P - Purchase I 0,5000 14.500 7 14.500
2019-10-01 2019-10-01 4 Beattie Nell VBIV Common Shares, no par value per share P - Purchase D 0,4822 10.000 5 60.000
2019-10-01 2019-10-01 4 McNulty Christopher VBIV Common Shares, no par value per share P - Purchase D 0,4730 12.000 6 37.000
2019-09-30 2019-09-30 4 Baxter Jeff VBIV Common Shares, no par value per share P - Purchase D 0,5030 150.000 75 608.255
2019-09-24 2019-09-23 4 PERCEPTIVE ADVISORS LLC VBIV Common Stock P - Purchase I 0,5000 20.000.000 10.000 45.951.556
2019-07-01 2019-06-27 4 Diaz-Mitoma Francisco VBIV Common Shares, no par value per share P - Purchase I 1,0700 8.000 9 77.500
2019-06-20 2019-06-20 4 Diaz-Mitoma Francisco VBIV Common Shares, no par value per share P - Purchase I 0,8900 42.000 37 69.500
2019-06-20 2019-06-20 4 Diaz-Mitoma Francisco VBIV Common Shares, no par value per share P - Purchase I 0,7800 10.000 8 27.500
2019-06-20 2019-06-18 4 PERCEPTIVE ADVISORS LLC VBIV Common Stock P - Purchase I 0,6500 1.000.000 650 25.951.556
2019-06-19 2019-06-19 4 Baxter Jeff VBIV Common Shares, no par value per share P - Purchase D 0,7315 144.000 105 458.255
2019-06-19 2019-06-19 4 Beattie Nell VBIV Common Shares, no par value per share P - Purchase D 0,7357 8.000 6 50.000
2019-06-18 2019-06-14 4 GILLIS STEVEN VBIV Restricted Stock Units (RSUs) M - Exercise D -18.750 0
2019-06-18 2019-06-14 4 GILLIS STEVEN VBIV Common Shares, no par value per share M - Exercise D 18.750 84.416
2019-06-18 2019-06-14 4 Baxter Jeff VBIV Restricted Stock Units (RSUs) M - Exercise D -31.250 0
2019-06-18 2019-06-14 4 Baxter Jeff VBIV Common Shares, no par value per share M - Exercise D 31.250 314.255
2019-06-18 2019-06-14 4 Beattie Nell VBIV Restricted Stock Units (RSUs) M - Exercise D -6.250 0
2019-06-18 2019-06-14 4 Beattie Nell VBIV Common Shares, no par value per share M - Exercise D 6.250 42.000
2019-06-18 2019-06-14 4 DeWilde Michel VBIV Restricted Stock Units (RSUs) M - Exercise D -12.500 0
2019-06-18 2019-06-14 4 DeWilde Michel VBIV Common Shares, no par value per share M - Exercise D 12.500 50.000
2019-06-18 2019-06-14 4 Anderson David Evander VBIV Restricted Stock Units (RSUs) M - Exercise D -21.875 0
2019-06-18 2019-06-14 4 Anderson David Evander VBIV Common Shares, no par value per share M - Exercise D 21.875 148.209
2019-06-18 2019-06-17 4 PERCEPTIVE ADVISORS LLC VBIV Common Stock P - Purchase I 0,6180 1.000.000 618 24.951.556
2019-04-24 2019-04-18 4 Cordeiro Joanne VBIV Option (Right to Buy Common Shares) A - Award D 1,97 200.000 200.000
2019-02-04 2019-01-31 4 Beattie Nell VBIV Option (Right to Buy Common Shares) A - Award D 1,67 300.000 300.000
2019-02-04 2019-01-31 4 Beattie Nell VBIV Common Shares, no par value per share A - Award D 15.000 35.750
2019-02-04 2019-01-31 4 Anderson David Evander VBIV Option (Right to Buy Common Shares) A - Award D 1,67 300.000 300.000
2019-02-04 2019-01-31 4 Anderson David Evander VBIV Common Shares, no par value per share A - Award D 25.000 126.334
2019-02-04 2019-01-31 4 Mazaltov Avi VBIV Common Share A - Award D 90.000 196.000
2019-02-04 2019-01-31 4 Requadt Scott VBIV Option (Right to Buy Common Shares) A - Award D 1,67 200.000 200.000
2019-02-04 2019-01-31 4 McNulty Christopher VBIV Option (Right to Buy Common Shares) A - Award D 1,67 300.000 300.000
2019-02-04 2019-01-31 4 McNulty Christopher VBIV Common Shares, no par value per share A - Award D 25.000 25.000
2019-02-04 2019-01-31 4 DeWilde Michel VBIV Option (Right to Buy Common Shares) A - Award D 1,67 200.000 200.000
2019-02-04 2019-01-31 4 Baxter Jeff VBIV Option (Right to Buy Common Shares) A - Award D 1,67 450.000 450.000
2019-02-04 2019-01-31 4 Baxter Jeff VBIV Common Shares, no par value per share A - Award D 50.000 283.005
2019-02-04 2019-01-31 4 Diaz-Mitoma Francisco VBIV Option (Right to Buy Common Shares) A - Award D 1,64 300.000 300.000
2019-02-04 2019-01-31 4 GILLIS STEVEN VBIV Option (Right to Buy Common Shares) A - Award D 1,67 300.000 300.000
2019-02-04 2019-01-31 4 McKee Blaine H. VBIV Option (Right to Buy Common Shares) A - Award D 1,67 300.000 300.000
2019-02-04 2019-01-31 4 Kariv Tomer VBIV Option (Right to Buy Common Shares) A - Award D 1,64 200.000 200.000
2018-12-18 2018-12-17 4 Kariv Tomer By Pontifax Late Stage Fund L.P. VBIV Common Stock P - Purchase I 1,4000 185.714 260 185.714
2018-12-18 2018-12-17 4 Kariv Tomer By Pontifax (China) IV Limited Partnership VBIV Common Stock P - Purchase I 1,4000 331.429 464 943.451
2018-12-18 2018-12-17 4 Kariv Tomer By Pontifax (Cayman) IV Limited Partnership VBIV Common Stock P - Purchase I 1,4000 298.431 418 849.520
2018-12-18 2018-12-17 4 Kariv Tomer By Pontifax (Israel) IV Limited Partnership VBIV Common Stock P - Purchase I 1,4000 612.997 858 1.744.969
2018-12-17 2018-12-13 4 PERCEPTIVE ADVISORS LLC VBIV Common Stock P - Purchase I 1,4000 14.285.714 20.000 23.631.439
2018-09-21 2018-09-19 4 McNulty Christopher VBIV Option (Right to Buy Common Shares) A - Award D 1,83 250.000 250.000
2018-08-07 2018-08-06 4 Baxter Jeff VBIV Common Shares, no par value per share P - Purchase D 1,9268 8.100 16 233.005
2018-08-06 2018-08-03 4 Diaz-Mitoma Francisco VBIV Common Shares, no par value per share P - Purchase I 2,1000 6.000 13 17.500
2018-08-06 2018-08-02 4 Diaz-Mitoma Francisco VBIV Common Shares, no par value per share P - Purchase I 2,2000 3.000 7 11.500
2018-08-06 2018-08-03 4 Baxter Jeff VBIV Common Shares, no par value per share P - Purchase D 2,0082 13.500 27 224.905
2018-08-03 2018-08-03 4 Beattie Nell VBIV Common Shares, no par value per share P - Purchase D 2,0057 2.000 4 20.750
2018-08-01 2018-07-31 4 Baxter Jeff VBIV Common Shares, no par value per share P - Purchase D 2,2760 16.800 38 211.405
2018-07-03 2018-06-14 4/A Anderson David Evander VBIV Common Shares, no par value per share F - Taxes D 3,7600 -9.281 -35 101.334
2018-06-29 2018-01-23 4/A Mazaltov Avi VBIV Option (Right to Buy Common Shares) A - Award D 4,19 0 0
2018-06-29 2018-01-23 4/A Mazaltov Avi VBIV Common Share A - Award D 100.000 106.000
2018-06-25 2018-06-14 4 GILLIS STEVEN VBIV Restricted Stock Units (RSUs) M - Exercise D -18.750 18.750
2018-06-25 2018-06-14 4 GILLIS STEVEN VBIV Common Shares, no par value per share M - Exercise D 18.750 65.666
2018-06-20 2018-06-14 4 DeWilde Michel VBIV Restricted Stock Units (RSUs) M - Exercise D -12.500 12.500
2018-06-20 2018-06-14 4 DeWilde Michel VBIV Common Shares, no par value per share M - Exercise D 12.500 37.500
2018-06-18 2018-06-14 4 Requadt Scott VBIV Restricted Stock Units (RSUs) M - Exercise D -12.500 12.500
2018-06-18 2018-06-14 4 Requadt Scott VBIV Common Shares, no par value per share M - Exercise D 12.500 37.500
2018-06-18 2018-06-14 4 Rubin Steven D VBIV Restricted Stock Units (RSUs) M - Exercise D -18.750 18.750
2018-06-18 2018-06-14 4 Rubin Steven D VBIV Common Shares, no par value per share M - Exercise D 18.750 56.250
2018-06-18 2018-06-14 4 Baxter Jeff VBIV Restricted Stock Units (RSUs) M - Exercise D -31.250 31.250
2018-06-18 2018-06-14 4 Baxter Jeff VBIV Common Shares, no par value per share M - Exercise D 31.250 194.605
2018-06-18 2018-06-14 4 Beattie Nell VBIV Restricted Stock Units (RSUs) M - Exercise D -6.250 6.250
2018-06-18 2018-06-14 4 Beattie Nell VBIV Common Shares, no par value per share M - Exercise D 6.250 18.750
2018-06-18 2018-06-14 4 Anderson David Evander VBIV Restricted Stock Units (RSUs) M - Exercise D -21.875 21.875
2018-06-18 2018-06-14 4 Anderson David Evander VBIV Common Shares, no par value per share F - Taxes D 3,7600 -9.306 -35 101.309
2018-06-18 2018-06-14 4 Anderson David Evander VBIV Common Shares, no par value per share M - Exercise D 21.875 110.615
2018-06-18 2018-06-14 4 Logal Adam VBIV Restricted Stock Units (RSUs) M - Exercise D -12.500 12.500
2018-06-18 2018-06-14 4 Logal Adam VBIV Common Shares, no par value per share M - Exercise D 12.500 37.500
2018-05-25 2018-05-24 4 Baxter Jeff VBIV Common Shares, no par value per share P - Purchase D 2,9900 11.000 33 163.355
2018-05-14 2018-05-11 4 Baxter Jeff VBIV Common Shares, no par value per share P - Purchase D 2,9100 7.100 21 152.355
2018-05-14 2018-05-11 4 Diaz-Mitoma Francisco VBIV Common Shares, no par value P - Purchase D 3,1300 4.500 14 268.839
2018-05-14 2018-05-11 4 Diaz-Mitoma Francisco VBIV Common Shares, no par value P - Purchase I 2,9800 5.500 16 8.500
2018-02-06 2018-01-23 4 Kartsaklis Athena VBIV Option (Right to Buy Common Shares) A - Award D 4,26 75.000 75.000
2018-01-30 3 Mazaltov Avi VBIV Common Shares, no par value per share D 12.000
2018-01-30 3 Mazaltov Avi VBIV Common Shares, no par value per share D 12.000
2018-01-30 2018-01-23 4 Mazaltov Avi VBIV Option (Right to Buy Common Shares) A - Award D 4,19 100.000 100.000
2018-01-29 3 Kariv Tomer By Pontifax (China) IV Limited Partnership VBIV Common Stock I 2.907.105
2018-01-29 3 Kariv Tomer By Pontifax (Israel) IV Limited Partnership VBIV Common Stock I 3.427.055
2018-01-29 3 Kariv Tomer By Pontifax (Cayman) IV Limited Partnership VBIV Common Stock I 2.846.172
2018-01-29 3 Kariv Tomer By Pontifax (China) IV Limited Partnership VBIV Common Stock I 2.907.105
2018-01-29 3 Kariv Tomer By Pontifax (Israel) IV Limited Partnership VBIV Common Stock I 3.427.055
2018-01-29 3 Kariv Tomer By Pontifax (Cayman) IV Limited Partnership VBIV Common Stock I 2.846.172
2018-01-29 2018-01-23 4 Kariv Tomer VBIV Option (Right to Buy Common Shares) A - Award D 4,19 75.000 75.000
2018-01-26 2018-01-23 4 DeWilde Michel VBIV Option (Right to Buy Common Shares) A - Award D 4,19 75.000 75.000
2018-01-25 2018-01-23 4 GILLIS STEVEN VBIV Option (Right to Buy Common Shares) A - Award D 4,19 100.000 100.000
2018-01-25 2018-01-23 4 Logal Adam VBIV Option (Right to Buy Common Shares) A - Award D 4,19 75.000 75.000
2018-01-25 2018-01-23 4 Rubin Steven D VBIV Option (Right to Buy Common Shares) A - Award D 4,19 75.000 75.000
2018-01-25 2018-01-23 4 Diaz-Mitoma Francisco VBIV Option (Right to Buy Common Shares) A - Award D 4,26 100.000 100.000
2018-01-25 2018-01-23 4 Beattie Nell VBIV Option (Right to Buy Common Shares) A - Award D 4,19 100.000 100.000
2018-01-25 2018-01-23 4 Anderson David Evander VBIV Option (Right to Buy Common Shares) A - Award D 4,19 100.000 100.000
2018-01-25 2018-01-23 4 Buckley T. Adam VBIV Option (Right to Buy Common Shares) A - Award D 4,19 75.000 75.000
2018-01-25 2018-01-23 4 Requadt Scott VBIV Option (Right to Buy Common Shares) A - Award D 4,19 75.000 75.000
2018-01-25 2018-01-23 4 Baxter Jeff VBIV Option (Right to Buy Common Shares) A - Award D 4,19 150.000 150.000
2017-12-13 2017-12-12 4 Baxter Jeff VBIV Common Shares, no par value per share P - Purchase D 3,8800 4.609 18 145.255
2017-12-13 2017-12-12 4 Baxter Jeff VBIV Common Shares, no par value per share P - Purchase D 3,8900 5.391 21 140.646
2017-11-29 2017-11-28 4 Baxter Jeff VBIV Common Shares, no par value per share P - Purchase D 4,7500 15.000 71 135.255
2017-11-09 3 Opko Health, Inc. VBIV Common Stock D 12.046.028
2017-11-09 3 Opko Health, Inc. VBIV Common Stock D 12.046.028
2017-11-01 2017-10-30 4 Opko Health, Inc. VBIV Common Stock P - Purchase D 3,0500 655.738 2.000 6.678.752
2017-10-31 3 Nussbaum Ran By Pontifax (Israel) IV Limited Partnership VBIV Common Shares, no par value per share I 3.427.055
2017-10-31 3 Nussbaum Ran By Pontifax (Cayman) IV Limited Partnership VBIV Common Shares, no par value per share I 2.846.172
2017-10-31 3 Nussbaum Ran By Pontifax (China) IV Limited Partnership VBIV Common Shares, no par value per share I 2.907.105
2017-10-31 3 Nussbaum Ran By Pontifax (Israel) IV Limited Partnership VBIV Common Shares, no par value per share I 3.427.055
2017-10-31 3 Nussbaum Ran By Pontifax (Cayman) IV Limited Partnership VBIV Common Shares, no par value per share I 2.846.172
2017-10-31 3 Nussbaum Ran By Pontifax (China) IV Limited Partnership VBIV Common Shares, no par value per share I 2.907.105
2017-10-31 2017-10-30 4 CHAWLA SAM VBIV Common Shares, no par value per share P - Purchase I 3,0500 3.100.000 9.455 9.345.725
2017-10-31 2017-10-30 4 GILLIS STEVEN VBIV Common Shares, no par value per share P - Purchase I 3,0500 300.000 915 3.026.057
2017-10-30 2017-10-26 4 PERCEPTIVE ADVISORS LLC VBIV Common Stock P - Purchase I 3,0500 3.100.000 9.455 9.345.725
2017-08-22 2017-08-21 4 Diaz-Mitoma Francisco VBIV Common Shares, no par value per share P - Purchase I 3,1700 3.000 10 3.000
2017-08-22 2017-08-21 4 Baxter Jeff VBIV Common Shares, no par value per share P - Purchase D 3,2200 10.000 32 120.255
2017-08-14 2017-08-10 4 Baxter Jeff VBIV Common Shares, no par value per share P - Purchase D 3,2800 10.000 33 110.255
2017-06-23 2017-06-22 4 Diaz-Mitoma Francisco VBIV Common Shares, no par value per share A - Award D 12.500 264.339
2017-06-16 2017-06-14 4 DeWilde Michel VBIV Restricted Stock Units (RSUs) M - Exercise D -12.500 25.000
2017-06-16 2017-06-14 4 DeWilde Michel VBIV Common Shares, no par value per share M - Exercise D 12.500 25.000
2017-06-16 2017-06-14 4 Buckley T. Adam VBIV Restricted Stock Units (RSUs) M - Exercise D -4.687 9.374
2017-06-16 2017-06-14 4 Buckley T. Adam VBIV Common Shares, no par value per share M - Exercise D 4.687 44.063
2017-06-16 2017-06-14 4 Rubin Steven D VBIV Restricted Stock Units (RSUs) M - Exercise D -18.750 37.500
2017-06-16 2017-06-14 4 Rubin Steven D VBIV Common Shares, no par value per share M - Exercise D 18.750 37.500
2017-06-16 2017-06-14 4 GILLIS STEVEN VBIV Restricted Stock Units (RSUs) M - Exercise D -18.750 37.500
2017-06-16 2017-06-14 4 GILLIS STEVEN VBIV Common Shares, no par value per share M - Exercise D 18.750 46.916
2017-06-16 2017-06-14 4 CHAWLA SAM VBIV Restricted Stock Units (RSUs) M - Exercise D -12.500 25.000
2017-06-16 2017-06-14 4 CHAWLA SAM VBIV Common Shares, no par value per share M - Exercise D 12.500 25.000
2017-06-16 2017-06-14 4 Requadt Scott VBIV Restricted Stock Units (RSUs) M - Exercise D -12.500 25.000
2017-06-16 2017-06-14 4 Requadt Scott VBIV Common Shares, no par value per share M - Exercise D 12.500 25.000
2017-06-16 2017-06-14 4 Anderson David Evander VBIV Restricted Stock Units (RSUs) M - Exercise D -21.875 43.750
2017-06-16 2017-06-14 4 Anderson David Evander VBIV Common Shares, no par value per share M - Exercise D 21.875 88.740
2017-06-16 2017-06-14 4 Baxter Jeff VBIV Restricted Stock Units (RSUs) M - Exercise D -31.250 62.500
2017-06-16 2017-06-14 4 Baxter Jeff VBIV Common Shares, no par value per share M - Exercise D 31.250 100.255
2017-06-16 2017-06-14 4 Beattie Nell VBIV Restricted Stock Units (RSUs) M - Exercise D -6.250 12.500
2017-06-16 2017-06-14 4 Beattie Nell VBIV Common Shares, no par value per share M - Exercise D 6.250 12.500
2017-06-16 2017-06-14 4 Logal Adam VBIV Restricted Stock Units (RSUs) M - Exercise D -12.500 25.000
2017-06-16 2017-06-14 4 Logal Adam VBIV Common Shares, no par value per share M - Exercise D 12.500 25.000
2017-04-27 3 Baxter Jeff VBIV Common Shares, no par value per share D 138.010
2017-04-27 3 Baxter Jeff VBIV Common Shares, no par value per share D 138.010
2017-04-27 3 DeWilde Michel VBIV Common Shares, no par value per share D 25.000
2017-04-27 3 DeWilde Michel VBIV Common Shares, no par value per share D 25.000
2017-04-27 2017-04-18 4 Baxter Jeff VBIV Option (Right to Buy Common Shares) A - Award D 3,79 20.000 20.000
2017-04-27 2017-04-17 4 DeWilde Michel VBIV Option (Right to Buy Common Shares) A - Award D 3,79 12.500 12.500
2017-04-04 3 Anderson David Evander VBIV Common Shares, no par value per share D 133.730
2017-04-04 3 Anderson David Evander VBIV Common Shares, no par value per share D 133.730
2017-04-04 3 Beattie Nell VBIV Common Shares, no par value per share D 12.500
2017-04-04 3 Beattie Nell VBIV Common Shares, no par value per share D 12.500
2017-04-04 3 Requadt Scott VBIV Common Shares, no par value per share D 2.716.042
2017-04-04 3 Requadt Scott VBIV Common Shares, no par value per share I 5.394.584
2017-04-04 3 Requadt Scott VBIV Common Shares, no par value per share D 2.716.042
2017-04-04 3 Requadt Scott VBIV Common Shares, no par value per share I 5.394.584
2017-04-04 2017-04-03 4 Beattie Nell VBIV Option (Right to Buy Common Shares) A - Award D 3,79 20.000 20.000
2017-04-04 2017-03-31 4 Requadt Scott VBIV Option (Right to Buy Common Shares) A - Award D 3,79 12.500 12.500
2017-04-04 2017-03-31 4 Anderson David Evander VBIV Option (Right to Buy Common Shares) A - Award D 3,79 20.000 20.000
2017-03-31 3 Logal Adam VBIV Common Shares, no par value per share D 25.000
2017-03-31 3 Logal Adam VBIV Common Shares, no par value per share D 25.000
2017-03-31 3 CHAWLA SAM VBIV Common Shares, no par value per share D 6.590.843
2017-03-31 3 CHAWLA SAM VBIV Common Shares, no par value per share I 13.144.186
2017-03-31 3 CHAWLA SAM VBIV Common Shares, no par value per share I 13.144.186
2017-03-31 3 CHAWLA SAM VBIV Common Shares, no par value per share D 6.590.843
2017-03-31 3 Nascimento Egidio VBIV Common Shares, no par value per share D 5.936
2017-03-31 3 Nascimento Egidio VBIV Common Shares, no par value per share D 5.936
2017-03-31 3 Buckley T. Adam VBIV Common Shares, no par value per share D 78.752
2017-03-31 3 Buckley T. Adam VBIV Common Shares, no par value per share D 78.752
2017-03-31 3 Rubin Steven D VBIV Common Shares, no par value per share D 37.500
2017-03-31 3 Rubin Steven D VBIV Common Shares, no par value per share D 37.500
2017-03-31 3 GILLIS STEVEN VBIV Common Shares, no par value per share I 5.473.903
2017-03-31 3 GILLIS STEVEN VBIV Common Shares, no par value per share D 2.769.635
2017-03-31 3 GILLIS STEVEN VBIV Common Shares, no par value per share I 5.473.903
2017-03-31 3 GILLIS STEVEN VBIV Common Shares, no par value per share D 2.769.635
2017-03-31 3 Eckenswiller Catherine VBIV Common Shares, no par value per share D 0
2017-03-31 3 Diaz-Mitoma Francisco VBIV Common Shares, no par value per share I 278.147
2017-03-31 3 Diaz-Mitoma Francisco VBIV Common Shares, no par value per share I 278.147
2017-03-31 3 Diaz-Mitoma Francisco VBIV Common Shares, no par value per share D 498.082
2017-03-31 3 Diaz-Mitoma Francisco VBIV Common Shares, no par value per share D 498.082
2017-03-31 2017-03-29 4 Diaz-Mitoma Francisco VBIV Option (Right to Buy Common Shares) A - Award D 3,45 20.000 20.000
2017-03-31 2017-03-29 4 Diaz-Mitoma Francisco VBIV Common Shares, no par value per share A - Award D 12.500 251.839
2017-03-31 2017-03-30 4 Rubin Steven D VBIV Option (Right to Buy Common Shares) A - Award D 3,79 12.500 12.500
2017-03-31 2017-03-29 4 GILLIS STEVEN VBIV Option (Right to Buy Common Shares) A - Award D 3,79 15.000 15.000
2017-03-31 2017-01-17 4 GILLIS STEVEN VBIV Option (Right to Buy Common Shares) M - Exercise D 2,50 2,5000 -6.377 -16 0
2017-03-31 2017-01-17 4 GILLIS STEVEN VBIV Common Shares, no par value per share M - Exercise D 2,5000 6.377 16 28.166
2017-03-31 2017-03-31 4 Eckenswiller Catherine VBIV Option (Right to Buy Common Shares) A - Award D 3,45 3.000 3.000
2017-03-31 2017-03-30 4 Nascimento Egidio VBIV Option (Right to Buy Common Shares) A - Award D 3,45 20.000 20.000
2017-03-31 2017-03-30 4 Buckley T. Adam VBIV Option (Right to Buy Common Shares) A - Award D 3,79 20.000 20.000
2017-03-31 2017-03-30 4 Logal Adam VBIV Option (Right to Buy Common Shares) A - Award D 3,79 12.500 12.500
2017-03-31 2017-03-30 4 CHAWLA SAM VBIV Option (Right to Buy Common Shares) A - Award D 3,79 12.500 12.500
P
Pasar terbuka atau pembelian swasta atas sekuritas non-derivatif atau derivatif
S
Pasar terbuka atau penjualan pribadi atas sekuritas non-derivatif atau derivatif
A
Hibah, penghargaan, atau perolehan sekuritas lainnya dari perusahaan (seperti opsi)
C
Konversi derivatif
D
Penjualan atau pengalihan surat berharga kembali kepada perusahaan
F
Pembayaran harga pelaksanaan atau kewajiban perpajakan dengan menggunakan sebagian surat berharga yang diterima dari perusahaan
G
Pemberian surat berharga oleh atau kepada insider
K
Swap ekuitas dan transaksi lindung nilai serupa
M
Penggunaan atau konversi sekuritas derivatif yang diterima dari perusahaan (seperti opsi)
V
Suatu transaksi dilaporkan secara sukarela pada Formulir 4
J
Lainnya (disertai catatan kaki yang menjelaskan transaksi)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista